These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33905300)

  • 21. Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination.
    Wen Y; Wang H; Wu H; Yang F; Tripp RA; Hogan RJ; Fu ZF
    J Virol; 2011 Feb; 85(4):1634-44. PubMed ID: 21106736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant rabies virus expressing the H protein of canine distemper virus protects dogs from the lethal distemper challenge.
    Wang FX; Zhang SQ; Zhu HW; Yang Y; Sun N; Tan B; Li ZG; Cheng SP; Fu ZF; Wen YJ
    Vet Microbiol; 2014 Dec; 174(3-4):362-371. PubMed ID: 25465178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monophosphoryl-Lipid A (MPLA) is an Efficacious Adjuvant for Inactivated Rabies Vaccines.
    Chen C; Zhang C; Li R; Wang Z; Yuan Y; Li H; Fu Z; Zhou M; Zhao L
    Viruses; 2019 Dec; 11(12):. PubMed ID: 31816996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A recombinant rabies virus expressing Echinococcus granulosus EG95 induces protective immunity in mice.
    Xu T; Liu L; Shi C; Liu W; Wang M; Tian L; Zheng Y; Wang H; Zheng W; He H; Xia X; Zheng X
    Transbound Emerg Dis; 2022 Jul; 69(4):e254-e266. PubMed ID: 34403194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of interleukin-6 by a recombinant rabies virus enhances its immunogenicity as a potential vaccine.
    Luo J; Zhang B; Wu Y; Tian Q; Zhao J; Lyu Z; Zhang Q; Mei M; Luo Y; Guo X
    Vaccine; 2017 Feb; 35(6):938-944. PubMed ID: 28089546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Novel Bacterial Protease Inhibitor Adjuvant in RBD-Based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection Against SARS-CoV-2 Infection in Mice.
    Coria LM; Saposnik LM; Pueblas Castro C; Castro EF; Bruno LA; Stone WB; Pérez PS; Darriba ML; Chemes LB; Alcain J; Mazzitelli I; Varese A; Salvatori M; Auguste AJ; Álvarez DE; Pasquevich KA; Cassataro J
    Front Immunol; 2022; 13():844837. PubMed ID: 35296091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetically modified rabies virus vector-based bovine ephemeral fever virus vaccine induces protective immune responses against BEFV and RABV in mice.
    Zheng W; Zhao Z; Tian L; Liu L; Xu T; Wang X; He H; Xia X; Zheng Y; Wei Y; Zheng X
    Transbound Emerg Dis; 2021 May; 68(3):1353-1362. PubMed ID: 32805767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.
    Shuai L; Wang X; Wen Z; Ge J; Wang J; Zhao D; Bu Z
    Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein.
    Amann R; Rohde J; Wulle U; Conlee D; Raue R; Martinon O; Rziha HJ
    J Virol; 2013 Feb; 87(3):1618-30. PubMed ID: 23175365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity of replication-deficient vesicular stomatitis virus based rabies vaccine in mice.
    Park JE; Shin HJ
    Vet Q; 2021 Dec; 41(1):202-209. PubMed ID: 33985418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and safety of recombinant rabies viruses used for oral vaccination of stray dogs and wildlife.
    Faber M; Dietzschold B; Li J
    Zoonoses Public Health; 2009 Aug; 56(6-7):262-9. PubMed ID: 19486317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoprotein.
    Chen Z; Zhou M; Gao X; Zhang G; Ren G; Gnanadurai CW; Fu ZF; He B
    J Virol; 2013 Mar; 87(6):2986-93. PubMed ID: 23269806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting Vaccine-Induced Extrafollicular Pathway of B Cell Differentiation Improves Rabies Postexposure Prophylaxis.
    Haley SL; Tzvetkov EP; Meuwissen S; Plummer JR; McGettigan JP
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymph node but not intradermal injection site macrophages are critical for germinal center formation and antibody responses to rabies vaccination.
    Lytle AG; Shen S; McGettigan JP
    J Virol; 2015 Mar; 89(5):2842-8. PubMed ID: 25540370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of interferon regulatory factor 7 in the pathogenicity and immunogenicity of rabies virus in a mouse model.
    Wang C; Lv L; Wu Q; Wang Z; Luo Z; Sui B; Zhou M; Fu ZF; Zhao L
    J Gen Virol; 2021 Oct; 102(10):. PubMed ID: 34661517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigating the role for IL-21 in rabies virus vaccine-induced immunity.
    Dorfmeier CL; Tzvetkov EP; Gatt A; McGettigan JP
    PLoS Negl Trop Dis; 2013; 7(3):e2129. PubMed ID: 23516660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective vaccine-induced CD4(+) T cell-independent B cell responses against rabies infection.
    Dorfmeier CL; Lytle AG; Dunkel AL; Gatt A; McGettigan JP
    J Virol; 2012 Nov; 86(21):11533-40. PubMed ID: 22896601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant rabies virus with the glycoprotein fused with a DC-binding peptide is an efficacious rabies vaccine.
    Zhang Y; Zhou M; Li Y; Luo Z; Chen H; Cui M; Fu ZF; Zhao L
    Oncotarget; 2018 Jan; 9(1):831-841. PubMed ID: 29416659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.
    Abkar M; Lotfi AS; Amani J; Eskandari K; Ramandi MF; Salimian J; Brujeni GN; Alamian S; Kamali M; Koushki H
    Vet Res Commun; 2015 Dec; 39(4):217-28. PubMed ID: 26395469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.